RMRavi Marwah

Ravi Marwah

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ravi Marwah has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Delays to Post‐Operative Radiotherapy in Patients With Head and Neck Squamous Cell Carcinoma: A Mixed‐Methods Analysis of Health Worker Perspectives

    by Ravi Marwah, Justin Smith, Daniel Goonetilleke, Liela Murison, Madhavi Chilkuri

    Introduction: Post‐operative radiation therapy (PORT) delays are associated with reduced survival and higher recurrence rates in patients with head and neck squamous cell carcinoma (HNSCC). This study explores health worker perspectives on barriers and solutions to timely PORT in an Australian regional centre with a large Aboriginal and Torres Strait Islander population. Methods: This paper incorporated an explanatory sequential mixed methods design. Head and neck multidisciplinary team (HNMDT) members involved in the care of patients with HNSCC at a regional tertiary centre were invited to participate. Participants completed an online survey and underwent semi‐structured focus groups/interviews. Results: Nineteen healthcare workers participated in the surveys. The three factors most attributed to PORT delays were rurality, surgery at an external facility and Indigenous status. Ten healthcare workers subsequently participated in focus groups/interviews. Three themes regarding solutions to PORT delays were identified: addressing care fragmentation, improving care coordination and ensuring cultural safety in Aboriginal and Torres Strait Islander care. Strategies proposed to address care fragmentation included streamlining referral pathways, utilising electronic reminders for clinicians and coordinators to prompt follow‐up, and increasing local service provision. Solutions suggested to improve care coordination included flagging patients early for follow‐up, timely organisation of transport and accommodation, and employing head and neck‐specific cancer care coordinators. Strategies proposed to ensure cultural safety included instituting cultural immersion programmes, promoting earlier Indigenous Liaison Officer engagement, supporting family involvement, and developing culturally appropriate patient resources. Conclusion: This study highlights barriers and solutions to timely PORT in an Australian regional centre with a large Aboriginal and Torres Strait Islander population. Strategies aimed at the patient and systems level and formed in partnership with Indigenous peoples must be instituted to address delays.

  • Open Access

    Return to work in patients with head and neck cancer: Systematic review and meta‐analysis

    by Justin Yu, Justin Smith, Ravi Marwah, Oskar Edkins

    Background: The aim of this review was to determine the prevalence of return to work (RTW) amongst head and neck cancer (HNC) survivors and to determine its impact on quality of life (QoL).Methods: A literature search was conducted in PubMed, Scopus, Embase and CINAHL in March 2021. Articles were included if they reported the number of patients with HNC receiving definitive treatment who were working at the time of diagnosis and returned to work.Results: There were 21 articles deemed eligible for inclusion. Meta‐analysis suggested that 67% of patients with HNC who were employed at diagnosis RTW (95% CI 62%–73%, I2 = 97.53%). Patients who RTW were demonstrated to have lower levels of anxiety and depressive symptoms on the Hospital Anxiety and Depression Scale.Conclusions: Return to work is an important clinical outcome which must be considered in the survivorship care of patients with HNC.


  • Open Access

    Evaluating delays in patients treated with post‐operative radiation therapy for head and neck squamous cell carcinoma

    by Ravi Marwah, Daniel Goonetilleke, Justin Smith, Madhavi Chilkuri

    Introduction: Delays in commencing post‐operative radiation therapy (PORT) and prolongation of overall treatment times (OTT) are associated with reduced overall survival and higher recurrence rates in patients with head and neck squamous cell carcinoma (HNSCC). The objective of this study was to evaluate treatment delays, factors contributing to those delays and to explore strategies to mitigate them.Methods: This retrospective study included patients with mucosal HNSCC at Townsville University Hospital treated with curative intent surgery and PORT between June 2011 and June 2019. The proportion of patients who experienced delays in commencing PORT (>6 weeks) and OTT were evaluated and reasons for these delays were explored.Results: The study included 94 patients of which 70% experienced PORT delay. Surgery at an external facility (81% vs 56%, P = 0.006) and longer post‐operative length of stay (P = 0.011) were significantly associated with a higher incidence of PORT delay. Aboriginal and Torres Strait Islander patients had a higher rate of PORT delay (89% vs 68.2%, P = 0.198). Significant delays were noted from time of surgery to radiation oncology (RO) consult and from RO consult to commencement of radiation treatment.Conclusion: This study demonstrates that the prevalence of PORT delay for patients with HNSCC remains high with room for improvement. Potential strategies to improve delays include developing effective care coordination, addressing specific needs of Indigenous patients, implementing reliable automated tracking and communication systems between teams and harnessing existing electronic referral systems.


  • Open Access

    Machine learning imaging applications in the differentiation of true tumour progression from treatment‐related effects in brain tumours: A systematic review and meta‐analysis

    by Abhishta Bhandari, Ravi Marwah, Justin Smith, Duy Nguyen, Asim Bhatti, Chee Peng Lim, Arian Lasocki

    Introduction: Chemotherapy and radiotherapy can produce treatment‐related effects, which may mimic tumour progression. Advances in Artificial Intelligence (AI) offer the potential to provide a more consistent approach of diagnosis with improved accuracy. The aim of this study was to determine the efficacy of machine learning models to differentiate treatment‐related effects (TRE), consisting of pseudoprogression (PsP) and radiation necrosis (RN), and true tumour progression (TTP).Methods: The systematic review was conducted in accordance with PRISMA‐DTA guidelines. Searches were performed on PubMed, Scopus, Embase, Medline (Ovid) and ProQuest databases. Quality was assessed according to the PROBAST and CLAIM criteria. There were 25 original full‐text journal articles eligible for inclusion.Results: For gliomas: PsP versus TTP (16 studies, highest AUC = 0.98), RN versus TTP (4 studies, highest AUC = 0.9988) and TRE versus TTP (3 studies, highest AUC = 0.94). For metastasis: RN vs. TTP (2 studies, highest AUC = 0.81). A meta‐analysis was performed on 9 studies in the gliomas PsP versus TTP group using STATA. The meta‐analysis reported a high sensitivity of 95.2% (95%CI: 86.6–98.4%) and specificity of 82.4% (95%CI: 67.0–91.6%).Conclusion: TRE can be distinguished from TTP with good performance using machine learning‐based imaging models. There remain issues with the quality of articles and the integration of models into clinical practice. Future studies should focus on the external validation of models and utilize standardized criteria such as CLAIM to allow for consistency in reporting.